LC
TNDM icon

Lindbrook Capital’s Tandem Diabetes Care TNDM Stock Holding History

Lindbrook Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.64K Sell
190
-90
-32% -$2.63K ﹤0.01% 2081
2024
Q4 		$10.1K Sell
280
-183
-40% -$6.19K ﹤0.01% 1643
2024
Q3 		$19.6K Sell
463
-210
-31% -$8.9K ﹤0.01% 1310
2024
Q2 		$27.1K Buy
673
+393
+140% +$16.4K ﹤0.01% 1078
2024
Q1 		$9.91K Buy
280
+90
+47% +$2.41K ﹤0.01% 1574
2023
Q4 		$5.62K Buy
190
+116
+157% +$2.41K ﹤0.01% 1826
2023
Q3 		$1.54K Sell
74
-19
-20% -$522 ﹤0.01% 2212
2023
Q2 		$2.28K Sell
93
-152
-62% -$4.89K ﹤0.01% 2105
2023
Q1 		$9.95K Buy
245
+203
+483% +$8.4K ﹤0.01% 1455
2022
Q4 		$1.89K Sell
42
-14
-25% -$634 ﹤0.01% 2252
2022
Q3 		$3K Buy
56
+7
+14% +$384 ﹤0.01% 1937
2022
Q2 		$3K Buy
49
+41
+513% +$3.37K ﹤0.01% 1850
2022
Q1 		$1K Buy
+8
New +$934 ﹤0.01% 2369

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's TNDM Position: Q1 2025 in Review

Lindbrook Capital reduced its Tandem Diabetes Care (TNDM) stake by 32% in Q1 2025, selling an estimated $2.63K and leaving 190 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

Lindbrook Capital first reported a position in TNDM in Q1 2022 and has held it in 13 quarters since. The position peaked at $27.1K in Q2 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Lindbrook Capital held 190 shares of Tandem Diabetes Care worth $3.64K as of Q1 2025.
  • Lindbrook Capital sold 90 Tandem Diabetes Care shares in Q1 2025, an estimated $2.63K.
  • Tandem Diabetes Care made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2081 holding.
  • Lindbrook Capital first reported a position in Tandem Diabetes Care in Q1 2022 and has held it in 13 quarters since.
  • Lindbrook Capital's Tandem Diabetes Care position peaked at $27.1K in Q2 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.